Haemonetics Corporation (HAE)

Return on assets (ROA)

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Net income (ttm)	US$ in thousands	167,679	130,065	123,812	114,889	117,558	126,574	128,277	136,566	115,401	95,759	86,047	67,706	43,375	22,593	31,243	64,488	79,469	108,134	106,147	95,532
Total assets	US$ in thousands	2,450,950	2,531,270	2,525,220	2,540,980	2,195,590	2,200,430	2,011,280	1,962,260	1,934,820	1,878,070	1,865,110	1,820,530	1,859,730	1,831,380	1,801,500	1,794,190	1,819,920	1,318,070	1,418,170	1,433,170
ROA		6.84%	5.14%	4.90%	4.52%	5.35%	5.75%	6.38%	6.96%	5.96%	5.10%	4.61%	3.72%	2.33%	1.23%	1.73%	3.59%	4.37%	8.20%	7.48%	6.67%

March 31, 2025 calculation

ROA = Net income (ttm) ÷ Total assets
= $167,679K ÷ $2,450,950K
= 6.84%

Haemonetics Corporation's return on assets (ROA) shows fluctuation over the period from June 30, 2020, to March 31, 2025. The ROA started at 6.67% on June 30, 2020, and gradually increased to 8.20% by December 31, 2020, demonstrating improving asset utilization efficiency. However, from March 31, 2021, the ROA declined, reaching its lowest point of 1.23% on December 31, 2021, indicating a decrease in the company's ability to generate profits from its assets.

The ROA showed a gradual recovery from March 31, 2022, onward, increasing to 6.96% by June 30, 2023. This improvement suggests that the company enhanced its efficiency in utilizing assets to earn profits during this period. Despite a slight decline to 4.52% by June 30, 2024, the ROA rebounded to 6.84% by March 31, 2025.

Overall, fluctuations in Haemonetics Corporation's ROA highlight the company's changing efficiency in generating profits from its assets. The upward trend after March 31, 2022, indicates improved asset utilization, supporting healthier financial performance. However, analysts may want to further investigate the factors contributing to the fluctuations in the ROA to better understand the company's financial health and performance.